What is Roth Capital’s Forecast for TSE:ELV Q2 Earnings?

Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV) – Equities research analysts at Roth Capital decreased their Q2 2025 EPS estimates for Invesco S&P Emerging Markets Low Volatility Index ETF in a research report issued on Friday, February 14th. Roth Capital analyst C. Irwin now expects that the company will earn $0.04 per share for the quarter, down from their prior estimate of $0.07. Roth Capital also issued estimates for Invesco S&P Emerging Markets Low Volatility Index ETF’s Q3 2025 earnings at $0.07 EPS and Q4 2025 earnings at $0.11 EPS.

Separately, Raymond James upgraded shares of Invesco S&P Emerging Markets Low Volatility Index ETF to a “strong-buy” rating in a research report on Wednesday, January 22nd.

Invesco S&P Emerging Markets Low Volatility Index ETF Stock Performance

Invesco S&P Emerging Markets Low Volatility Index ETF has a 12-month low of C$17.53 and a 12-month high of C$20.15. The stock’s 50-day moving average price is C$19.26.

Invesco S&P Emerging Markets Low Volatility Index ETF Company Profile

Elevance Health Inc operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.